Nocebo Education to Reduce the Potential Unintended Harms of Mental Health Awareness
1 other identifier
interventional
215
1 country
1
Brief Summary
This project has two aims. First, the research team will confirm whether providing a mental health awareness workshop poses unintended harms by raising the rate of self-diagnosis (as opposed to a neutral workshop) and causing worsening symptoms in previously healthy young adults over a period of one week. The study will focus on determining this in the context of ADHD, as it includes broad symptoms that overlap with normal experience, is commonly overdiagnosed, and is included in many awareness campaigns for neurodiversity and mental health. Second, the study will test whether nocebo effect education, or in other words, learning about the nocebo effects, during mental health awareness sessions "inoculates" against them. Simply learning about the role negative expectations play in creating side effects has been shown to reduce nocebo side effects of medications; perhaps, the same applies to mental health. Researchers will compare the outcome of the ADHD workshop with that of the same workshop but with nocebo information included; both experimental conditions will also be compared to an active control condition. Participants are hypothesised to report the following pattern of symptoms: ADHD information \> ADHD + nocebo education \> Control During the study participants will:
- 1.Randomize the participants to one of the three workshop conditions to watch
- 2.Report self-diagnosis score immediately after the workshop and 1 week later.
- 3.Report symptoms 1 week later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
October 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2024
CompletedFebruary 19, 2025
February 1, 2025
2 months
October 9, 2024
February 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Self-reported ADHD symptoms
As measured by Adult ADHD Self-Reported Symptom Scale (ASRS), a self-reported scale of ADHD symptoms with a score range of 0-72, with a higher score indicating worse symptoms.
Change 1 week
Self-diagnosis with ADHD
As measured by one item with a score range from 1 to 5, with a higher score indicating stronger self-diagnosing belief.
Change: Immediate, 1 week
Secondary Outcomes (2)
Memory Failures
Change, 1 week
Depressive and Anxiety Symptoms
Change, 1 week
Study Arms (3)
ADHD information workshop
EXPERIMENTALADHD information workshop with nocebo education
EXPERIMENTALSleep and dreams workshop
ACTIVE COMPARATORInterventions
ADHD information workshop that will be delivered by a clinical psychology student in one 30-minute session to a group of participants. The workshop will present information about lesser-known or commonly misdiagnosed ADHD symptoms. To control for the duration of the nocebo module (see the condition below), participants will also learn about sleep and its relevance for maintenance of good cognitive health. At the end, the workshop will involve a writing reflection activity about personal experiences with ADHD symptoms.
ADHD information workshop that will be delivered by a clinical psychology student in one 30-minute session to a group of participants. The workshop will present information about lesser-known or commonly misdiagnosed ADHD symptoms, together with a module on nocebo effects and their potential role in worsening symptoms. The nocebo module will describe the current understanding of the role of expectations in creating side effects and elaborate on how this applies to the field of mental health through a series of examples. It will also involve a writing reflection activity about personal experiences with ADHD symptoms, potential for nocebo effect when talking about ADHD symptoms, and ability to apply this information to personal experiences.
An information workshop about sleep and dream experiences that will be delivered by a clinical psychologist in one 30-minute session to a group of participants. It will be matched on duration, type of content, and engagingness with the experimental sessions.
Eligibility Criteria
You may qualify if:
- No existing diagnosis of ADHD, or history/current diagnosis of any other neurological/psychiatric disorder.
- Score below 18 on the Adult ADHD Self-Reported Symptom (ASRS) Checklist Screener.
- No current intake of medication to treat a psychiatric disorder (e.g., antidepressants)
- Fluent in English;
- Access to a computer, tablet, or smartphone with internet capability;
- Normal or corrected-to-normal vision and hearing.
You may not qualify if:
- Diagnosis of ADHD or any other neurological/psychiatric disorder.
- Active intake of medication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Toronto
Toronto, Ontario, M1C 1A4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Participants will be blinded to the study hypotheses and treatment arms, and to the type of intervention they are receiving. Outcome assessors will be blinded to participants' treatment arm assignment and the type of intervention they are receiving.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 9, 2024
First Posted
October 15, 2024
Study Start
October 16, 2024
Primary Completion
December 8, 2024
Study Completion
December 8, 2024
Last Updated
February 19, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
Researchers will share anonymised data by depositing it in a data repository (e.g., Open Science Framework). We will also provide the statistical analysis plan for the data analysis.